CFAP300: A Potential Drug Target and Biomarker (G85016)

Target Name: CFAP300

NCBI ID: G85016

CFAP300

CFAP300: A Potential Drug Target and Biomarker

Cilia and flagella associated protein (CFAP) 300 is a protein that is expressed in the cilia, which are small hair-like structures that line the surface of various body cells. CFAP300 is a 21-kDa protein that is composed of 205 amino acid residues. It has been shown to be involved in various cellular processes, including cell signaling, cytoskeletal organization, and intracellular transport.

CFAP300 has been identified as a potential drug target due to its involvement in several diseases, including cancer, neurodegenerative diseases, and respiratory disorders. Its expression has also been increased in several types of cancer, which suggests that targeting CFAP300 may be an effective way to treat these diseases.

One of the key challenges in studying CFAP300 is its high degree of homogeneity. Despite its small size, CFAP300 has a complex structure that includes multiple domains, including an N-terminal transmembrane domain, a coiled-coil domain, and a C-terminal T-loop domain. The N-terminal transmembrane domain is responsible for the protein's ability to interact with various cell surface receptors, while the coiled-coil domain is responsible for its ability to form helices and to influence the structure and function of the protein. The C-terminal T-loop domain is involved in the regulation of CFAP300's stability and interactions with other cellular components.

While much research has been done on CFAP300, relatively little is known about its functions in specific diseases. However, studies have shown that CFAP300 is involved in several cellular processes that are important for normal cellular function.

One of the key functions of CFAP300 is its role in intracellular signaling. CFAP300 has been shown to be involved in several signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These pathways are involved in various cellular processes, including cell growth, differentiation, and inflammation.

In addition to its role in intracellular signaling, CFAP300 is also involved in the regulation of cytoskeletal organization. CFAP300 has been shown to be involved in the organization and stability of microtubules, which are important for the proper functioning of cells.

CFAP300's role in intracellular transport is also of interest. Studies have shown that CFAP300 is involved in the regulation of the transport of various molecules, including nucleotides, amino acids, and proteins. This suggests that CFAP300 may be involved in the proper functioning of intracellular transport systems.

While CFAP300 has been studied extensively, relatively little is known about its potential clinical applications. However, its potential as a drug target and biomarker makes it an attractive target for future research.

In conclusion, CFAP300 is a small protein that is involved in various cellular processes that are important for normal cellular function. Its potential as a drug target and biomarker makes it an attractive target for future research. Further studies are needed to fully understand its functions in diseases and to develop effective treatments.

Protein Name: Cilia And Flagella Associated Protein 300

Functions: Cilium- and flagellum-specific protein that plays a role in axonemal structure organization and motility. May play a role in outer and inner dynein arm assembly

The "CFAP300 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CFAP300 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets